Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
15 August 2023, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE:
Read More